ES2061571T3 - Derivados de urea. - Google Patents

Derivados de urea.

Info

Publication number
ES2061571T3
ES2061571T3 ES88112393T ES88112393T ES2061571T3 ES 2061571 T3 ES2061571 T3 ES 2061571T3 ES 88112393 T ES88112393 T ES 88112393T ES 88112393 T ES88112393 T ES 88112393T ES 2061571 T3 ES2061571 T3 ES 2061571T3
Authority
ES
Spain
Prior art keywords
group
groups
atoms
carbon
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88112393T
Other languages
English (en)
Inventor
Hiroshi Matsukubo
Toyomi Matsumoto
Mitsutomo Miyashita
Kyuya Okamura
Fukutaro Taga
Haruo Sekiguchi
Katsuhiro Hamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2061571T3 publication Critical patent/ES2061571T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADOS DE LA UREA QUE CORRESPONDEN A LA SIGUIENTE FORMULA(I), EN LA QUE R1 REPRESENTA UN GRUPO PIPERIDINO O PIRROLIDINO QUE PUEDE SER SUSTITUIDO CON UN GRUPO HIDROXI O UN GRUPO ALQUILO DE 1 A 3 ATOMOS DE CARBONO.; A REPRESENTA UN ETILENO, PROPILENO, BUTILENO BUTENILENO; R2 REPRESENTA UNA CADENA ALQUILO LINEAL O RAMIFICADA DE 1 A 20 ATOMOS DE CARBONO, UN GRUPO CICLOALQUIL DE 3 A 6 ATOMOS DE CARBONO, UN GRUPO BENCILO O UN GRUPO FENILO QUE PUEDE PRESENTAR 1 A 3 SUSTITUYENTES COMO POR EJEMPLO GRUPOS ALQUILO INFERIORES DE 1 A 6 ATOMOS DE CARBONO, GRUPOS ALCOXI INFERIORES DE 1 A 3 ATOMOS DE CARBONO, GRUPOS HALOGENURO, GRUPOS TRIFLUOROMETILO, AMINO, NITRO O METILENDIOXI;X REPRESENTA UN ATOMO DE OXIGENO O AZUFRE. LOS HIDRATOS Y SALES DERIVANTES DE ACIDOS FARMACEUTICAMENTE ACEPTABLES PRESENTAN ACTIVIDAD COMO AGENTES ANTIULCERANTES.
ES88112393T 1987-08-03 1988-07-29 Derivados de urea. Expired - Lifetime ES2061571T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19406087 1987-08-03
JP63168887A JPH0639466B2 (ja) 1987-08-03 1988-07-08 ウレア誘導体

Publications (1)

Publication Number Publication Date
ES2061571T3 true ES2061571T3 (es) 1994-12-16

Family

ID=26492411

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88112393T Expired - Lifetime ES2061571T3 (es) 1987-08-03 1988-07-29 Derivados de urea.

Country Status (10)

Country Link
US (2) US4952591A (es)
EP (1) EP0302422B1 (es)
JP (1) JPH0639466B2 (es)
KR (1) KR960008246B1 (es)
CN (1) CN1019889C (es)
AU (1) AU611705B2 (es)
CA (1) CA1327200C (es)
DE (1) DE3886125T2 (es)
ES (1) ES2061571T3 (es)
HU (1) HU201304B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06247933A (ja) * 1992-03-23 1994-09-06 Sankyo Co Ltd ピリジルオキシ誘導体
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE46886B1 (en) * 1977-05-17 1983-10-19 Allen & Hanburys Ltd Aminoalkyl-benzene derivatives
GB1604674A (en) * 1977-05-17 1981-12-16 Allen & Hanburys Ltd Aminoalkyl-benzene derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
GB2038322B (en) * 1978-11-16 1982-11-24 Glaxo Group Ltd Amine derivatives
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
US4293557A (en) * 1979-07-03 1981-10-06 Teikoku Hormone Mfg. Co., Ltd. Antiulcer phenoxypropylamine derivatives
GB2064515B (en) * 1979-10-23 1983-06-29 Glaxo Group Ltd Heterocyclic derivatives processes for their production and pharmaceutical compositions containing them
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
EP0057981A3 (en) * 1981-02-09 1982-08-25 Beecham Group Plc Aromatic compounds, processes for their preparation and their use
CA1254212A (en) * 1982-11-12 1989-05-16 Shiro Hirai Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
DE3438073A1 (de) * 1984-10-17 1986-04-24 Ludwig Heumann & Co GmbH, 8500 Nürnberg Butenylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
CN1019889C (zh) 1993-02-10
DE3886125D1 (de) 1994-01-20
KR890003690A (ko) 1989-04-17
US4952591A (en) 1990-08-28
EP0302422A2 (en) 1989-02-08
CA1327200C (en) 1994-02-22
AU2024788A (en) 1989-02-09
JPH01139563A (ja) 1989-06-01
CN1032009A (zh) 1989-03-29
HUT47906A (en) 1989-04-28
DE3886125T2 (de) 1994-06-23
EP0302422B1 (en) 1993-12-08
US5077302A (en) 1991-12-31
JPH0639466B2 (ja) 1994-05-25
HU201304B (en) 1990-10-28
EP0302422A3 (en) 1990-02-07
AU611705B2 (en) 1991-06-20
KR960008246B1 (ko) 1996-06-21

Similar Documents

Publication Publication Date Title
ES2196806T3 (es) Derivados de fenilurea y de feniltiourea.
NL971014I1 (nl) Heterocyclische verbindingen.
ES2173683T3 (es) Inhibidor del radical superoxido.
ES2111654T3 (es) Derivados de piperazina como antagonistas de 5-ht1a.
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
MX9300988A (es) Agentes antineoplasticos de quinobenzoxazina, quinobenzotiazina y pirido-acridina y composicion farmaceutica que los contiene.
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
ES8501362A1 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES2151110T3 (es) Derivados de piridazinona y procedimiento de preparacion.
SE8505887D0 (sv) Indoler
IT1226100B (it) Derivati benzimidazolici farmacologicamente attivi.
MY102744A (en) Aromatic derivatives, their preparation and thier use as antimicrobial agents.
ES2057262T3 (es) Derivados del cromano.
UY24425A1 (es) Derivados de tiol con actividad inhibidora de metalopeptidasa.
ES431020A1 (es) Procedimiento para la preparacion de derivados de 1,4-dihi- dro-2h-isoquinoleina.
FI91876B (fi) Menetelmä nootrooppisen vaikutuksen omaavien aminohappojohdannaisten valmistamiseksi
ES2061571T3 (es) Derivados de urea.
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES501929A0 (es) Procedimiento para la preparacion de tienobenzodiazepinonas substituidas
AR027578A1 (es) Derivados de indano
ES2052711T3 (es) Compuestos biologicamente activos.
DE68906965D1 (de) Analgetische phenothiazinderivate.
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
ES2058874T3 (es) 1-acil-2-pirrolidinonas como mejoradores del entendimiento y memoria y composiciones farmaceuticas que las contienen.
DE3879322D1 (de) Benzimidazol-derivate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 302422

Country of ref document: ES